Expert Opinion on Drug Safety

Antipsychotic-induced sudden cardiac death: examination of an atypical reaction
pp. 249-252(4)
Author: Killeen, Dr. Matthew J

Risks and benefits of allergen immunotherapy
pp. 253-256(4)
Authors: Rogala, Barbara; Glück, Joanna

Thrombotic microangiopathy associated with gemcitabine: rare but real
pp. 257-260(4)
Authors: Saif, M Wasif; Xyla, Vassilia; Makrilia, Nektaria; Bliziotis, Ioannis; Syrigos, Kostas

Statins and the risk of Parkinson disease: an update on the controversy
pp. 261-271(11)
Authors: Becker, Claudia; Meier, Christoph R

Suicidality and montelukast
pp. 273-282(10)
Authors: Manalai, Partam; Woo, Jong-Min; Postolache, Teodor T

The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology
pp. 283-303(21)
Author: Czeizel, Andrew E

Safety of conditioning agents for allogeneic haematopoietic transplantation
pp. 305-315(11)
Authors: Bacher, Ulrike; Klyuchnikov, Evgeny; Wiedemann, Bettina; Kroeger, Nicolaus; Zander, Axel Rolf

Serotonergic drugs and valvular heart disease
pp. 317-329(13)
Authors: Rothman, Richard B; Baumann, Michael H

Immune mediation of hypersensitivity adverse drug reactions: implications for therapy
pp. 331-343(13)
Author: Rieder, Michael J

Non-investigational antiarrhythmic drugs: long-term use and limitations
pp. 345-355(11)
Author: Gjesdal, Knut

Oseltamivir for treatment and prophylaxis of influenza infection
pp. 357-371(15)
Authors: Schirmer, Patricia; Holodniy, Mark

A review of the safety and tolerability of aripiprazole
pp. 373-386(14)
Author: Pae, Chi-Un

Safety and pharmacological profile of tiotropium bromide
pp. 387-395(9)
Authors: Santus, Pierachille; Di Marco, Fabiano